KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
72 hedge funds and large institutions have $242M invested in Kindred Biosciences, Inc. in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
32% less call options, than puts
Call options by funds: $89K | Put options by funds: $130K
47% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 19
Holders
72
Holding in Top 10
2
Calls
$89K
Puts
$130K
Top Buyers
| 1 | +$1.86M | |
| 2 | +$1.71M | |
| 3 | +$1.67M | |
| 4 |
SAM
Silverback Asset Management
Chapel Hill,
North Carolina
|
+$1.48M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$931K |
Top Sellers
| 1 | -$3.78M | |
| 2 | -$2.56M | |
| 3 | -$1.96M | |
| 4 |
Two Sigma Investments
New York
|
-$1.21M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.08M |